Amifampridine Phosphate Suppliers & Bulk Manufacturers

Amifampridine phosphate is used to treat Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder that affects the connection between nerves and muscles, causing muscle weakness. The medication helps improve muscle strength by enhancing the release of acetylcholine at the neuromuscular junction, improving nerve signal transmission to muscles. 

Amifampridine phosphate is made from the active ingredient amifampridine phosphate, a potassium channel blocker that prolongs nerve terminal depolarization and increases acetylcholine release. Its chemical name is 3,4-diaminopyridine phosphate. Inactive ingredients may include mannitol, magnesium stearate, and microcrystalline cellulose depending on the formulation. 

The trade names of amifampridine phosphate are Firdapse and Amifampridine Phosphate Ruzurgi (for specific regions and indications). 

Amifampridine phosphate (Firdapse) is manufactured and marketed by Catalyst Pharmaceuticals in the United States and BioMarin Pharmaceutical in Europe. 

The generic name of the drug is amifampridine phosphate. 

The brand names of amifampridine phosphate are Firdapse and Ruzurgi. 

Amifampridine phosphate is manufactured in the United States by Catalyst Pharmaceuticals and in Europe by BioMarin Pharmaceutical, with distribution across North America, the European Union, and other global markets.